Change of Name

Summary by AI ^BETAClose X

Ovoca Bio PLC has officially changed its name to Talisman Metals PLC, following shareholder approval on January 27, 2026, and subsequent registration with the Companies Registration Office. Trading under the new name and the TIDM 'TLM' is expected to commence on AIM on February 6, 2026.

Disclaimer*

Ovoca Bio PLC

05 February 2026

Ovoca Bio Plc (to be renamed Talisman Metals PLC)

("Talisman" or the "Company")

Name and TIDM Change

Dublin, Ireland, 5 February 2026 - Talisman announces it has now received approval from the Companies Registration Office for its name change to Talisman Metals PLC after a shareholder vote on 27 January 2026 approving such change. As such, on 6 February 2026 it is expected that trading in the name Talisman Metals PLC on AIM with the TIDM 'TLM' will become effective.

End

For further information:

Talisman Metals PLC

Tim McCutcheon (Chief Executive Officer)

Tel +353 (0) 1 525 6710

contactus@talismanmetalsplc.com

Beaumont Cornish Limited (Nominated Adviser)

James Biddle / Roland Cornish

Tel: +44 (0) 207 628 3396

CMC Markets UK Plc (Broker)

Thomas Smith / Thomas Curran

Tel: +44 (0) 20 3003 8255

BlytheRay (Financial PR)

Megan Ray / Said Izagaren

Tel: +44 207 138 3204

talismanmetals@blytheray.com

Nominated Adviser Statement

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other person for providing the protections afforded to customers of Beaumont Cornish nor for advising them in relation to the transaction and arrangements described in the announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END